EYA4 exerts its tumor-suppressive functions mainly through deactivation of β-catenin/inhibitor of DNA binding 2 (ID2) cascade7, raising the possibility that TRIM69 might thwart the EYA4-driven deactivation of β-catenin/ID2 cascade. This evidence concerns the gene ID2 and neoplasm.